US Spending Bill to Provide New Funds for Science and Health

The legislation, passed by the House of Representatives yesterday, will increase research agencies’ budgets by around 5 percent in 2022 and support the creation of a new health agency.

Written byCatherine Offord
| 1 min read
US Capitol on a sunny day
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Update (March 15): The budget has now been signed into law by US president Joe Biden, according to CBS News, averting a partial government shutdown.

A spending bill passed yesterday by the US House of Representatives will, if enacted, increase the federal research budget and help launch a new health agency, among other initiatives. The plans, described in a 2,741-page document, would end a spending freeze that had prevented agencies from expanding their programs since last fall, Science reports, although some of the increases fall short of scientists’ hopes.

The National Science Foundation (NSF) is slated to receive $8.8 billion in 2022, a 4 percent increase on its previous budget. President Joe Biden’s administration had requested a 20 percent increase, according to Science.

The National Institutes of Health (NIH) will see an overall increase of around 5 percent, to a total budget of $45 billion, Science reports. The bill also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies